April 14-18 was presented with at the American Association for Cancer Study Annual Meeting held.

Avalon Pharmaceuticals announces outcomes of AVN944 biomarker study Avalon Pharmaceuticals offers announced the outcomes of an AVN944 biomarker research that utilized Avalon’s proprietary AvalonRx technology to recognize gene signatures which may be useful for individual stratification vardenafil 10mg tablets http://vardenafilcanadian.com . The poster demonstration entitled ‘Modulation of Gene Expression and Guanosine Pools by Inhibition of Inosine Monophosphate Dehydrogenase ; correlating In Vitro Cell Level of resistance with Biomarker Response in Individual Samples from the Stage I Trial,april 14-18 ‘ was presented with at the American Association for Cancer Study Annual Meeting held, 2007, in LA.